News The latest from Lumen Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic Project includes funding for preliminary engineering work on facility to manufacture over 1 billion doses per year Lumen Bioscience Announces Appointment of Mike Spigarelli as Chief Medical Officer Experienced Industry Leader to Advance Lumen’s Clinical Pipeline Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs Lead therapeutic candidates for widespread enteric diseases including C. difficile, norovirus, and traveler’s diarrhea Camelid Nanobodies Poised to Revolutionize Antibody Therapeutics August 26th, 2020 Genetic Engineering & Biotechnology News Lysins Unlimited: Phages’ Secret Weapon Antibacterial campaigns may simply requisition the organisms’ battle-tested cell-wall-breaching enzymes Fred Hutch and Adaptive Biotechnologies vets raise $13M for biotech startup Lumen is chasing the $1.5 billion market for natural colorants with technology that uses Spirulina. Pagination Current page 1 Page 2 Page 3 Pagination_arrow Next page Next › Last page Last »
